Resistance to chemotherapies, particularly to anticancer treatments, is an increasing medical concern. Among the many mechanisms at work in cancers, one of the most important is the selection of tumor cells expressing resistance genes or phenotypes. Motivated by the theory of mutation-selection in adaptive evolution, we propose a model based on a continuous variable that represents the expression level of a resistance gene (or genes, yielding a phenotype) influencing in healthy and tumor cells birth/death rates, effects of chemotherapies (both cytotoxic and cytostatic) and mutations. We extend previous work by demonstrating how qualitatively different actions of chemotherapeutic and cytostatic treatments may induce different levels of resistance. The mathematical interest of our study is in the formalism of constrained Hamilton-Jacobi equations in the framework of viscosity solutions. We derive the long-term temporal dynamics of the fittest traits in the regime of small mutations. In the context of adaptive cancer management, we also analyse whether an optimal drug level is better than the maximal tolerated dose. © EDP Sciences, SMAI, 2013.
Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies / Lorz, A.; Lorenzi, T.; Hochberg, M. E.; Clairambault, J.; Perthame, B.. - In: MODÉLISATION MATHÉMATIQUE ET ANALYSE NUMÉRIQUE. - ISSN 0764-583X. - ELETTRONICO. - 47:2(2013), pp. 377-399.
|Titolo:||Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies|
|Data di pubblicazione:||2013|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1051/m2an/2012031|
|Appare nelle tipologie:||1.1 Articolo in rivista|
File in questo prodotto:
|2870819preprint.pdf||pre-print autore||1. Preprint / Submitted Version||PUBBLICO - Tutti i diritti riservati||Visibile a tuttiVisualizza/Apri|
|2870819pdfedit.pdf||articolo principale||2a Post-print versione editoriale / Version of Record||Non Pubblico - Accesso privato/ristretto||Administrator Richiedi una copia|